Risk factors for death in patients with candidemia

Infection Control and Hospital Epidemiology

Volumn 19, Issue 11, 1998, Pages 846-850

  Nucci, Marcio ^a   Colombo, Arnaldo L ^b   Silveira, Fernanda ^a   Richtmann, Rosana ^c   Salomão, Reinaldo ^b,d   Branchini, Maria Luiza ^e   Spector, Nelson ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital do Publico Estadual   (Brazil)

^d Division of Infectious Diseases   (Brazil)

^e UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BRAZIL; CANDIDIASIS; CHILD; CLINICAL TRIAL; CROSS INFECTION; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD; PROSPECTIVE STUDY; PUBLIC HOSPITAL; RISK FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAZIL; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; HOSPITALS, PUBLIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0032199099     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141563     Document Type: Article

References (23)

1. Bodey GP. The emergence of fungi as major hospital pathogens. J Hosp Infect 1988;11:411-426.
2. Beck-Sagué CM, Jarvis WR, the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993;167:1247-1251.
3. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91(suppl 3B):86-89.
4. Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med 1989;87:614-620.
5. Pfaller M, Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 1992;11:287-291.
6. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642-2645.
7. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997;24:1068-1078.
8. Karnofsky DA, Burchenot JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLead CM, ed. Evaluation of Chemotherapeutic Agents. New York, NY: New York Columbia University Press; 1949:191-205.
9. Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995;20:1531-1534.
10. Miller PJ, Wenzel RP. Etiologic organisms as independent predictors of death and mortality associated with bloodstream infections. J Infect Dis 1987;156:471-477.
11. Nguyen MH, Peacock JE, Tanner DC, Morris AJ, Nguyen ML, Syndman DR, et al. Therapeutic approaches in patients with candidemia. Arch Intern Med 1995;155:2429-2435.
12. Fraser JF, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in tertiary care hospital. Epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:414-421.
13. Meuníer-Carpentíer F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host Changing patterns, antigenemia, high mortality. Am J Med 1981;71:363-370.
14. Martino P, Girmenia C, Micozzi A, Raccah R, Gentile G, Venditi M, et al. Fungemia in patients with leukemia. Am J Med Sci 1993;306:225-232.
15. Weems JJ Jr. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 1992;14:756-766.
16. Edwards, JE, Bodey GP, Bowden RA, Büchner T, de Pauw BE, Filler SG, et al. International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 1997;25:43-59.
17. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992;14(suppl 1):S43-S53.
18. Eppes SC, Troutman JL, Gutman LT. Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatr Infect Dis J 1989;8:99-104.
19. Dato VM, Dajani AS. Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatr Infect Dis J 1990;9:309-314.
20. Lecciones JA, Lee JW, Navarro EE, Witebsky FG, Marshall D, Steinberg SM, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992;14:875-883.
21. Nucci M, Silveira MI, Velasco E, Perecmanis T, Martins CA, Spector N, et al. Risk factors for death in cancer patients with fungemia. Clin Infect Dis 1998;27:107-111.
22. Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994;32:452-456.
23. Uzun O, Anaissie EJ. Problems and controversies in the management of hematogenous candidiasis. Clin Infect Dis 1996;22(suppl 2):S95-S101.